Phuong N. Huynh

Array ( [id] => 6996272 [patent_doc_number] => 20050136050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Bispecific antibodies' [patent_app_type] => utility [patent_app_number] => 10/743697 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6768 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136050.pdf [firstpage_image] =>[orig_patent_app_number] => 10743697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7161422 [patent_doc_number] => 20050084906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Novel anti-IGF-IR antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/735916 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 41745 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084906.pdf [firstpage_image] =>[orig_patent_app_number] => 10735916 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7275097 [patent_doc_number] => 20040234548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Microbial delivery system' [patent_app_type] => new [patent_app_number] => 10/728051 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12364 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234548.pdf [firstpage_image] =>[orig_patent_app_number] => 10728051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7424798 [patent_doc_number] => 20040208894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Microbial delivery system' [patent_app_type] => new [patent_app_number] => 10/728323 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12350 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20040208894.pdf [firstpage_image] =>[orig_patent_app_number] => 10728323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7249541 [patent_doc_number] => 20040258685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Therapy of non-malignant diseases or disorders with anti-ErbB2 antibodies' [patent_app_type] => new [patent_app_number] => 10/719310 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 31974 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20040258685.pdf [firstpage_image] =>[orig_patent_app_number] => 10719310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 606567 [patent_doc_number] => 07153932 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-26 [patent_title] => 'Immunotoxins comprising ribosome-inactivating proteins' [patent_app_type] => utility [patent_app_number] => 10/717243 [patent_app_country] => US [patent_app_date] => 2003-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 39676 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/153/07153932.pdf [firstpage_image] =>[orig_patent_app_number] => 10717243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 709633 [patent_doc_number] => 07056516 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD-95 induced apoptosis' [patent_app_type] => utility [patent_app_number] => 10/713208 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 22674 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/056/07056516.pdf [firstpage_image] =>[orig_patent_app_number] => 10713208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5857904 [patent_doc_number] => 20060228355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-12 [patent_title] => 'Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor' [patent_app_type] => utility [patent_app_number] => 10/553105 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20013 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20060228355.pdf [firstpage_image] =>[orig_patent_app_number] => 10553105 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 299715 [patent_doc_number] => 07537914 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-05-26 [patent_title] => 'Nucleic acid and allergenic polypeptides encoded thereby in cashew nuts (Anacardium occidentale)' [patent_app_type] => utility [patent_app_number] => 10/529602 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7300 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/537/07537914.pdf [firstpage_image] =>[orig_patent_app_number] => 10529602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5693737 [patent_doc_number] => 20060153884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Peptide fragments of the harp factor inhibiting angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/533443 [patent_app_country] => US [patent_app_date] => 2003-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9229 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153884.pdf [firstpage_image] =>[orig_patent_app_number] => 10533443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7449206 [patent_doc_number] => 20040067527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'Intracellular delivery system for protein phosphatases and other polypeptides' [patent_app_type] => new [patent_app_number] => 10/343163 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9770 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067527.pdf [firstpage_image] =>[orig_patent_app_number] => 10343163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7010806 [patent_doc_number] => 20050064522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'EG-VEGF nucleic acids and polypeptides and methods of use' [patent_app_type] => utility [patent_app_number] => 10/692299 [patent_app_country] => US [patent_app_date] => 2003-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 42860 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064522.pdf [firstpage_image] =>[orig_patent_app_number] => 10692299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7250090 [patent_doc_number] => 20050142126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Peroxisome-associated polypeptide, nucleotide sequence encoding said polypeptide and their uses in the diagnosis and/or the treatment of lung injuries and diseases, and of oxidative stress-related disorders' [patent_app_type] => utility [patent_app_number] => 10/686157 [patent_app_country] => US [patent_app_date] => 2003-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11404 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142126.pdf [firstpage_image] =>[orig_patent_app_number] => 10686157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7473757 [patent_doc_number] => 20040121955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Methods for modulating angiogenesis' [patent_app_type] => new [patent_app_number] => 10/686428 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 21258 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20040121955.pdf [firstpage_image] =>[orig_patent_app_number] => 10686428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5894381 [patent_doc_number] => 20060002920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Pharmaceutical compositions directed to erb-b1 receptors' [patent_app_type] => utility [patent_app_number] => 10/530871 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16192 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002920.pdf [firstpage_image] =>[orig_patent_app_number] => 10530871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 697919 [patent_doc_number] => 07067128 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype' [patent_app_type] => utility [patent_app_number] => 10/680160 [patent_app_country] => US [patent_app_date] => 2003-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18347 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067128.pdf [firstpage_image] =>[orig_patent_app_number] => 10680160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351121 [patent_doc_number] => 20040248781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Therapeutic method for reducing angiogenesis' [patent_app_type] => new [patent_app_number] => 10/203399 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9124 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248781.pdf [firstpage_image] =>[orig_patent_app_number] => 10203399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7449148 [patent_doc_number] => 20040067520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-08 [patent_title] => 'OB fusion protein compositions and methods' [patent_app_type] => new [patent_app_number] => 10/679999 [patent_app_country] => US [patent_app_date] => 2003-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13545 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20040067520.pdf [firstpage_image] =>[orig_patent_app_number] => 10679999 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7164799 [patent_doc_number] => 20040076625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Enhanced vaccines' [patent_app_type] => new [patent_app_number] => 10/673594 [patent_app_country] => US [patent_app_date] => 2003-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10910 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20040076625.pdf [firstpage_image] =>[orig_patent_app_number] => 10673594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7349311 [patent_doc_number] => 20040047864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Apoptosis inducing molecule I' [patent_app_type] => new [patent_app_number] => 10/662431 [patent_app_country] => US [patent_app_date] => 2003-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20078 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20040047864.pdf [firstpage_image] =>[orig_patent_app_number] => 10662431 [rel_patent_id] =>[rel_patent_doc_number] =>)